MoneyWorks4Me

Alivus Life Sciences - Quaterly Results

23 Jan 2026 Evaluate
With no major difference for the quarter endedDecember 2025 , the total revenue stood at Rs. 6728.89  millions.The Company has registered profit of Rs. 1502.61  millions for the quarter ended December 2025, a growth of 9.71%  over Rs. 1369.60 millions millions achieved in the corresponding quarter of last year.Operating profit surged to 2452.01 millions from the corresponding previous quarter of 2007.64 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 6728.89 6418.44 4.84 18627.15 17373.39 7.22 23868.84 22832.14 4.54
Other Income 139.28 104.56 33.21 376.33 244.82 53.72 345.70 120.42 187.08
PBIDT 2452.01 2007.64 22.13 6203.87 5086.34 21.97 7171.54 6862.88 4.50
Interest 14.94 4.58 226.20 40.63 11.54 252.08 24.14 15.46 56.14
PBDT 2180.50 2003.06 8.86 5906.67 5074.80 16.39 7147.40 6847.42 4.38
Depreciation 196.58 151.59 29.68 551.57 446.39 23.56 606.09 534.52 13.39
PBT 1983.92 1851.47 7.15 5355.10 4628.41 15.70 6541.31 6312.90 3.62
TAX 481.31 481.87 -0.12 1336.88 1190.82 12.27 1685.04 1604.02 5.05
Deferred Tax -57.85 13.81 -518.90 8.85 45.19 -80.42 60.64 81.88 -25.94
PAT 1502.61 1369.60 9.71 4018.22 3437.59 16.89 4856.27 4708.88 3.13
Equity 245.36 245.07 0.12 245.36 245.07 0.12 245.07 245.05 0.01
PBIDTM(%) 36.44 31.28 16.50 33.31 29.28 13.76 30.05 30.06 -0.04
Peers
Company Name CMP
Sun Pharma. Inds. 1843.75
Dr. Reddys Labs. 1215.65
Cipla 1389.90
Lupin 2065.00
Zydus Lifesciences 1223.70
View more..